A series of diimine ligands has been designed on the basis of 2-pyridyl-1H-phenanthro[9,10-d]imidazole (L1, L2). Coupling the basic motif of L1 with anthracene-containing fragments affords the bichromophore compounds L3–L5, of which L4 and L5 adopt a donor–acceptor architecture. The latter allows intramolecular charge transfer with intense absorption bands in the visible spectrum (lowest λ_abs 464 nm (ε = 1.2 × 10⁴ M^–1 cm^–1) and 490 nm (ε = 5.2 × 10⁴ M^–1 cm^–1) in CH₂Cl₂ for L4 and L5, respectively). L1–L5 show strong fluorescence in a fluid medium (Φ_em = 22–92%, λ_em 370–602 nm in CH₂Cl₂); discernible emission solvatochromism is observed for L4 and L5. In addition, the presence of pyridyl (L1–L5) and dimethylaminophenyl (L5) groups enables reversible alteration of their optical properties by means of protonation. Ligands L1–L5 were used to synthesize the corresponding [Re(CO)₃X(diimine)] (X = Cl, 1–5; X = CN, 1-CN) complexes. 1 and 2 exhibit unusual dual emission of singlet and triplet parentage, which originate from independently populated ¹ππ* and ³MLCT excited states. In contrast to the majority of the reported Re(I) carbonyl luminophores, complexes 3–5 display moderately intense ligand-based fluorescence from an anthracene-containing secondary chromophore and complete quenching of emission from the ³MLCT state presumably due to the triplet–triplet energy transfer (³MLCT → ³ILCT).

A series of square planar [Pt(N^C)(NHC)L] complexes containing cyclometallated N^C ligands (phenylpyridine and benzoquinoline) and N-heterocyclic carbene (NHC) – N^C = 2-phenylpyridine, 7,8-benzoquinoline; NHC = 1,3-dibenzylbenzimidazolium, 1,3-diethylbenzimidazolium, 1,3-dibenzylimidazolium; L = Cl, Br, –C₂Ph – have been synthesized in moderate to good yields. The complexes obtained were characterized using chemical analysis, MS-ESI spectrometry, NMR spectroscopy and X-ray crystallography. The complexes display moderate to strong phosphorescence in solution (Q.Y. 0.3–7.9%) and in the solid state (Q.Y. 2.7–16.0%), which is related to metal modulated intraligand π–π* transitions located at the aromatic system of cyclometallated ligands with some contribution of the MLCT excited state. Emission lifetimes fall in the range of 0.2–1.5 μs in solution and amount up to 13 μs in the solid state. Analysis of the spectroscopic data together with the density functional theory (DFT) and time-dependent density functional theory (TDDFT) calculations clearly support this assignment and show negligible contribution of the auxiliary ligands to the emissive excited states. The compounds obtained were also used to prepare organic light emitting diode (OLED) devices, which display good luminance efficiency emitting in the green area of the visible spectrum.

This paper presents synthesis and photophysical investigation of cyclometalated water-soluble Pt(II) and Ir(III) complexes containing auxiliary sulfonated diphosphine (bis(diphenylphosphino)benzene (dppb), P^P*) ligand. The complexes demonstrate considerable variations in excitation (extending up to 450 nm) and emission bands (with maxima ranging from ca. 450 to ca. 650 nm), as well as in the sensitivity of excited state lifetimes to molecular oxygen (from almost negligible to more than 4-fold increase in degassed solution). Moreover, all the complexes possess high two-photon absorption cross sections (400–500 GM for Pt complexes, and 600–700 GM for Ir complexes). Despite their negative net charge, all the complexes demonstrate good uptake by HeLa cells and low cytotoxicity within the concentration and time ranges suitable for two-photon phosphorescence lifetime (PLIM) microscopy. The most promising complex, [(ppy)₂Ir(sulfo-dppb)] (Ir1*), upon incubation in HeLa cells demonstrates two-fold lifetime variations under normal and nitrogen atmosphere, correspondingly. Moreover, its in vivo evaluation in athymic nude mice bearing HeLa tumors did not reveal acute toxicity upon both intravenous and topical injections. Finally, Ir1* demonstrated statistically significant difference in lifetimes between normal tissue (muscle) and tumor in macroscopic in vivo PLIM imaging.